← Eichor
Condition: Encephalitis Autoimmune Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Encephalitis Autoimmune

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
Phase 2 · 17 location(s) · Jena University Hospital · NCT03993262Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06079294Lupus Landmark Study: A Prospective Registry and Biorepository
Phase N/A · 25 location(s) · Lupus Research Alliance · NCT05934149Long-term Impact of NMDAR Encephalitis, Level 3
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07158229A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease
Phase 2 · 1 location(s) · Arialys Australia Pty Ltd · NCT07093333Collection of Biological Samples From Patients With Rare Neurological Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT04698421Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
NA · 62 location(s) · Hospices Civils de Lyon · NCT05198661Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT06510283Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
NA · 1 location(s) · Tongji Hospital · NCT06584045Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in
EARLY_Phase 1 · 1 location(s) · Tianjin Huanhu Hospital · NCT06939166Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT01730131FDG-PET in the Diagnosis of Autoimmune Encephalitis
Phase N/A · 6 location(s) · University of Milano Bicocca · NCT06019975Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Phase N/A · 13 location(s) · University of Bern · NCT05017142Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease
NA · 1 location(s) · Fundacion Clinic per a la Recerca Biomédica · NCT06515106Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07477015Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous Sys
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT04561557Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06941584Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Media
Phase 1 · 1 location(s) · Tongji Hospital · NCT07526493Biomarkers in Autoimmune Disease of Nervous System
Phase N/A · 1 location(s) · Tongji Hospital · NCT06502015MUSic Therapy In Complex Specialist Neurorehabilitation
NA · 1 location(s) · University College, London · NCT05777499Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Phase 3 · 2 location(s) · The First People's Hospital of Changzhou · NCT06867991The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Phase 2 · 39 location(s) · University of Utah · NCT04372615High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Im
NA · 8 location(s) · University Hospital, Angers · NCT06863974Cohort Study on Neuroimmune Diseases in the Reproductive Age
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT07653984Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?
Phase 2 · 1 location(s) · University Hospital, Toulouse · NCT07488117Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT05772611CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT07337785A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
Phase N/A · 1 location(s) · Shen Chun-Hong · NCT06173076Medium-term Effects of Treatments in Autoimmune Encephalitis
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07133113
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.